This article has been updated from a previous version to include comments made by CombiMatrix CEO Mark McDonough in an earnings call.

NEW YORK (GenomeWeb) - CombiMatrix reported today that its third quarter revenues rose 29 percent year over year, supported by a 14 percent increase in test volume across the company's menu of assays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.